Seong-Shin Kwak

Title: Seong-Shin Kwak: Innovator in Pharmaceutical Formulations

Introduction

Seong-Shin Kwak is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical formulations, holding a total of three patents. His work focuses on improving the efficacy and usability of various medications.

Latest Patents

Kwak's latest patents include a preparation comprising an inclusion complex of varenicline or its pharmaceutically acceptable salt for oral administration. This innovative formulation enhances the convenience of medication by effectively masking the bitter taste of the drug and reducing irritation during swallowing. Additionally, it provides oxidation stability for varenicline and improves the drug's solubility. Another significant patent involves a pharmaceutical composition containing clomipramine and a preparation method for it. This formulation combines clomipramine with sildenafil, improving the stability of clomipramine and utilizing a wet granulation method for manufacturing.

Career Highlights

Seong-Shin Kwak is currently associated with Ctc Bio, Inc., where he continues to develop innovative pharmaceutical solutions. His expertise in the field has led to advancements that benefit both healthcare providers and patients.

Collaborations

Kwak has collaborated with notable colleagues, including Hong Ryeol Jeon and Bong-Sang Lee, contributing to the success of various projects and enhancing the research environment at Ctc Bio, Inc.

Conclusion

Seong-Shin Kwak's contributions to pharmaceutical formulations demonstrate his commitment to innovation and improving medication usability. His patents reflect a deep understanding of the challenges in drug formulation, making a significant impact in the pharmaceutical industry.